Practical Retina

, and

Ophthalmic Surgery, Lasers and Imaging Retina, 2021;52(4):174–180

Published Online:April 01, 2021https://doi.org/10.3928/23258160-20210330-01Cited by:1

1.Urayama A, Sasaki T, Nishiyama Yet al.. Unilateral acute uveitis with periarteritis and detachment. Jpn J Ophthalmol. 1971;( 25):607–619.
> Google Scholar
2.Butler NJ, Moradi A, Salek SSet al.. Acute Retinal Necrosis: Presenting Characteristics and Clinical Outcomes in a Cohort of Polymerase Chain Reaction-Positive Patients. Am J Ophthalmol. 2017; 179:179–189. 10.1016/j.ajo.2017.05.006 PMID:28501392
> Crossref Medline Google Scholar
3.Fisher JP, Lewis ML, Blumenkranz Met al.. The acute retinal necrosis syndrome. Part 1: clinical manifestations. Ophthalmology. 1982; 89(12):1309–1316. 10.1016/S0161-6420(82)34628-X PMID:7162777
> Crossref Medline Google Scholar
4.Ganatra JB, Chandler D, Santos C, Kuppermann B, Margolis TP. Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol. 2000; 129(2):166–172. 10.1016/S0002-9394(99)00316-5 PMID:10682968
> Crossref Medline Google Scholar
5.Schoenberger SD, Kim SJ, Thorne JEet al.. Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017; 124(3):382–392. 10.1016/j.ophtha.2016.11.007 PMID:28094044
> Crossref Medline Google Scholar
6.Lau CH, Missotten T, Salzmann J, Lightman SL. Acute retinal necrosis features, management, and outcomes. Ophthalmology. 2007; 114(4):756–762. 10.1016/j.ophtha.2006.08.037 PMID:17184841
> Crossref Medline Google Scholar
7.Guex-Crosier Y, Rochat C, Herbort CP. Necrotizing herpetic retinopathies. A spectrum of herpes virus-induced diseases determined by the immune state of the host. Ocul Immunol Inflamm. 1997; 5(4):259–265. 10.3109/09273949709085066 PMID:9455742
> Crossref Medline Google Scholar
8.Schaal S, Kagan A, Wang Y, Chan C-C, Kaplan HJ. Acute retinal necrosis associated with Epstein-Barr virus: immunohistopathologic confirmation. JAMA Ophthalmol. 2014; 132(7):881–882. 10.1001/jamaophthalmol.2014.266 PMID:24743882
> Crossref Medline Google Scholar
9.Hillenkamp J, Nölle B, Bruns C, Rautenberg P, Fickenscher H, Roider J. Acute retinal necrosis: clinical features, early vitrectomy, and outcomes. Ophthalmology. 2009; 116(10):1971–5.e2. 10.1016/j.ophtha.2009.03.029 PMID:19592111
> Crossref Medline Google Scholar
10.Blumenkranz MS, Culbertson WW, Clarkson JG, Dix R. Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology. 1986; 93(3):296–300. 10.1016/S0161-6420(86)33740-0 PMID:3703498
> Crossref Medline Google Scholar
11.Palay DA, Sternberg P, Davis Jet al.. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol. 1991; 112(3):250–255. 10.1016/S0002-9394(14)76725-X PMID:1882936
> Crossref Medline Google Scholar
12.Aslanides IM, De Souza S, Wong DTWet al.. Oral valacyclovir in the treatment of acute retinal necrosis syndrome. Retina. 2002; 22(3):352–354. 10.1097/00006982-200206000-00016 PMID:12055471
> Crossref Medline Google Scholar
13.Emerson GG, Smith JR, Wilson DJ, Rosenbaum JT, Flaxel CJ. Primary treatment of acute retinal necrosis with oral antiviral therapy. Ophthalmology. 2006; 113(12):2259–2261. 10.1016/j.ophtha.2006.05.063 PMID:16996614
> Crossref Medline Google Scholar
14.Aizman A, Johnson MW, Elner SG. Treatment of acute retinal necrosis syndrome with oral antiviral medications. Ophthalmology. 2007; 114(2):307–312. 10.1016/j.ophtha.2006.06.058 PMID:17123607
> Crossref Medline Google Scholar
15.Wong RW, Jumper JM, McDonald HRet al.. Emerging concepts in the management of acute retinal necrosis. Br J Ophthalmol. 2013; 97(5):545–552. 10.1136/bjophthalmol-2012-301983 PMID:23235944
> Crossref Medline Google Scholar
16.Shantha JG, Weissman HM, Debiec MR, Albini TA, Yeh S. Advances in the management of acute retinal necrosis. Int Ophthalmol Clin. 2015; 55(3):1–13. 10.1097/IIO.0000000000000077 PMID:26035758
> Crossref Medline Google Scholar
17.Risseeuw S, de Boer JH, Ten Dam-van Loon NH, van Leeuwen R. Risk of Rhegmatogenous Retinal Detachment in Acute Retinal Necrosis With and Without Prophylactic Intervention. Am J Ophthalmol. 2019; 206:140–148. 10.1016/j.ajo.2019.05.023 PMID:31170391
> Crossref Medline Google Scholar
18.Clarkson JG, Blumenkranz MS, Culbertson WW, Flynn HW, Lewis ML. Retinal detachment following the acute retinal necrosis syndrome. Ophthalmology. 1984; 91(12):1665–1668. 10.1016/S0161-6420(84)34107-0 PMID:6151638
> Crossref Medline Google Scholar
19.Meghpara B, Sulkowski G, Kesen MR, Tessler HH, Goldstein DA. Long-term follow-up of acute retinal necrosis. Retina. 2010; 30(5):795–800. 10.1097/IAE.0b013e3181c7013c PMID:20057342
> Crossref Medline Google Scholar
20.Han DP, Lewis H, Williams GA, Mieler WF, Abrams GW, Aaberg TM. Laser photocoagulation in the acute retinal necrosis syndrome. Arch Ophthalmol. 1987; 105(8):1051–1054. 10.1001/archopht.1987.01060080053027 PMID:3632413
> Crossref Medline Google Scholar
21.Park JJ, Pavesio C. Prophylactic laser photocoagulation for acute retinal necrosis. Does it raise more questions than answers? Br J Ophthalmol. 2008; 92(9):1161–1162. 10.1136/bjo.2008.147181 PMID:18723739
> Crossref Medline Google Scholar
22.Sternberg P, Han DP, Yeo JHet al.. Photocoagulation to prevent retinal detachment in acute retinal necrosis. Ophthalmology. 1988; 95(10):1389–1393. 10.1016/S0161-6420(88)32999-4 PMID:3226687
> Crossref Medline Google Scholar
23.Crapotta JA, Freeman WR, Feldman RMet al.. Visual outcome in acute retinal necrosis. Retina. 1993; 13(3):208–213. 10.1097/00006982-199313030-00004 PMID:8235101
> Crossref Medline Google Scholar
24.Kim DY, Jo J, Joe SG, Lee JY, Yoon YH, Kim J-G. Clinical feature and visual prognosis of acute retinal necrosis according to the initially involved zone and extent: 10-year experience. Eur J Ophthalmol. 2019; 29(2):244–250. 10.1177/1120672118787438 PMID:29998748
> Crossref Medline Google Scholar
25.Schlingemann RO, Bruinenberg M, Wertheim-van Dillen P, Feron E. Twenty years' delay of fellow eye involvement in herpes simplex virus type 2-associated bilateral acute retinal necrosis syndrome. Am J Ophthalmol. 1996; 122(6):891–892. 10.1016/S0002-9394(14)70390-3 PMID:8956648
> Crossref Medline Google Scholar
26.Abedi G, Subramanian ML, Feinberg E, Ness SD. The role of intravenous immunoglobulin in treatment of acute retinal necrosis. Retin Cases Brief Rep. 2011; 5(4):363–365. 10.1097/ICB.0b013e318217383b PMID:25390437
> Crossref Medline Google Scholar
27.Liang Z-G, Liu Z-L, Sun X-W, Tao M-L, Yu G-P. Viral encephalitis complicated by acute retinal necrosis syndrome: A case report. Exp Ther Med. 2015; 10(2):465–467. 10.3892/etm.2015.2557 PMID:26622338
> Crossref Medline Google Scholar
28.Saraiva VS. Acute retinal necrosis and immune reconstitution inflammatory syndrome in a natalizumab-treated patient with multiple sclerosis. Retin Cases Brief Rep. 2015; 9(3):195–197. 10.1097/ICB.0000000000000136 PMID:25933353
> Crossref Medline Google Scholar
29.Navarro-Navarro A, Martinez-Toldos JJ, Tarazona-Jaimes CP, Fernandez-Martinez C, Baeza-Diaz MV. Presumed bilateral acute retinal necrosis 11 years apart, atypical presentation, and early vitrectomy. Eur J Ophthalmol. 2015; 25(5):e81–e83. 10.5301/ejo.5000596 PMID:25743780
> Crossref Medline Google Scholar
30.Schechet SA, Garff K, Klima K, Campbell W, Schocket LS. ACUTE RETINAL NECROSIS AFTER ADMINISTRATION OF ADALIMUMAB, A SYSTEMIC ANTITUMOR NECROSIS FACTOR ANTIBODY. Retin Cases Brief Rep. 2018; 12(4):307–309. 10.1097/ICB.0000000000000499 PMID:27997458
> Crossref Medline Google Scholar
31.Sims JL, Yeoh J, Stawell RJ. Acute retinal necrosis: a case series with clinical features and treatment outcomes. Clin Exp Ophthalmol. 2009; 37(5):473–477. 10.1111/j.1442-9071.2009.02083.x PMID:19624343
> Crossref Medline Google Scholar
32.Tibbetts MD, Shah CP, Young LH, Duker JS, Maguire JI, Morley MG. Treatment of acute retinal necrosis. Ophthalmology. 2010; 117(4):818–824. 10.1016/j.ophtha.2009.09.001 PMID:20079537
> Crossref Medline Google Scholar
33.Cochrane TF, Silvestri G, McDowell C, Foot B, McAvoy CE. Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study. Eye (Lond). 2012; 26(3):370–377. 10.1038/eye.2011.338 PMID:22281865
> Crossref Medline Google Scholar
34.Roy R, Pal BP, Mathur G, Rao C, Das D, Biswas J. Acute retinal necrosis: clinical features, management and outcomes—a 10 year consecutive case series. Ocul Immunol Inflamm. 2014; 22(3):170–174. 10.3109/09273948.2013.819928 PMID:24738972
> Crossref Medline Google Scholar
35.Jalali S, Kolari RS, Pathengay A, Athmanathan S. Severe hemorrhagic retinopathy as initial manifestation of acute retinal necrosis caused by herpes simplex virus. Indian J Ophthalmol. 2007; 55(4):308–310. 10.4103/0301-4738.33050 PMID:17595486
> Crossref Medline Google Scholar
36.Baltinas J, Lightman S, Tomkins-Netzer O. Comparing Treatment of Acute Retinal Necrosis With Either Oral Valacyclovir or Intravenous Acyclovir. Am J Ophthalmol. 2018; 188:173–180. 10.1016/j.ajo.2018.02.001 PMID:29447915
> Crossref Medline Google Scholar
37.Brydak-Godowska J, Borkowski P, Szczepanik S, Moneta-Wielgoś J, Kęcik D. Clinical manifestation of self-limiting acute retinal necrosis. Med Sci Monit. 2014; 20:2088–2096. 10.12659/MSM.890469 PMID:25356955
> Crossref Medline Google Scholar
38.Hsu C, Moinfar N, Lipman B, Capone A, Trese M. Acute retinal necrosis in a neonate. Retin Cases Brief Rep. 2013; 7(4):406–408. 10.1097/ICB.0b013e318297f6d5 PMID:25383815
> Crossref Medline Google Scholar

Information

Seenu M. Hariprasad, MD, can be reached at University of Chicago, Department of Ophthalmology and Visual Science, 5841 S. Maryland Ave., Room S-439, Chicago, IL 60637; email: retina@uchicago.edu.

Lincoln T. Shaw, MD, can be reached at University of Chicago Department of Ophthalmology and Visual Science, 5841 S. Maryland Avenue, MC 2114, Chicago, IL 60637; email: lincolnshawmd@gmail.com.

Dimitra Skondra, MD, PhD, can be reached at University of Chicago Department of Ophthalmology and Visual Science, 5841 S. Maryland Avenue, MC 2114, Chicago, IL 60637; email: dimitraskondra@gmail.com.

Disclosures: Dr. Hariprasad is a consultant or on the speakers bureau for Allergan, Novartis, Biogen, Graybug, EyePoint, Alimera Sciences, Spark, and Regeneron. Drs. Shaw and Skondra report no relevant financial disclosures.

Published online4/01/21

Verify Phone

Congrats!

The Utility of Prophylactic Laser Photocoagulation in Acute Retinal Necrosis: Current Perspectives

Information

SUBSCRIBER SERVICES

Account Information

RESOURCES

OPPORTUNITIES

Healio.com

HELP/INFORMATION

Legal

Request Username

Create a new account

Change Password

Your password must have 8 characters or more and contain 3 of the following:

Password Changed Successfully

Verify Phone

Congrats!

Cite this article

The Utility of Prophylactic Laser Photocoagulation in Acute Retinal Necrosis: Current Perspectives

Information

SUBSCRIBER SERVICES

Account Information

RESOURCES

OPPORTUNITIES

Healio.com

HELP/INFORMATION

Legal